Jared Teo is a Principal at HealthQuest Capital, a growth equity fund focused on investing in commercial-stage companies within medical technologies, digital health, innovative services, and diagnostics, since 2018. In addition to this role, Jared serves on the board of Inbound Health and Alcresta Therapeutics, with the latter being a company focused on rare diseases that was acquired by Linden Capital. Other board positions include CleanSlate Centers, a national outpatient addiction treatment network, and Etairos Health, a home healthcare organization. Jared has also contributed as a board observer for Ajax Health, mPulse Mobile, PipelineRx, and Seamless Medical Systems during their periods of operation up to their respective acquisitions. Prior experience includes working with the California Health Care Foundation's Health Innovation Fund, where significant investments were made in healthcare technology and services. Jared holds an MBA from The Wharton School and a degree in Bioengineering from UC San Diego.